Pfizer 2009 Annual Report Download - page 68

Download and view the complete annual report

Please find page 68 of the 2009 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 110

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110

Notes to Consolidated Financial Statements
Pfizer Inc. and Subsidiary Companies
8. Other Comprehensive Income/(Expense)
Changes, net of tax, in accumulated other comprehensive income/(expense) and the components of comprehensive income follow:
NET UNREALIZED
GAINS /(LOSSES) BENEFIT PLANS
ACCUMULATED
OTHER
COMPREHENSIVE
INCOME/(EXPENSE)(MILLIONS OF DOLLARS)
CURRENCY
TRANSLATION
ADJUSTMENT
AND OTHER
DERIVATIVE
FINANCIAL
INSTRUMENTS
AVAILABLE
FOR-SALE
SECURITIES
ACTUARIAL
GAINS/
(LOSSES)
PRIOR
SERVICE
(COSTS)/
CREDITS
AND
OTHER
Balance, January 1, 2007 $ 2,227 $ (26) $ 96 $(2,739) $ (27) $ (469)
Other comprehensive income/
(expense)—Pfizer Inc(a):
Foreign currency translation
adjustments 1,422 — — — — 1,422
Unrealized holding gains/
(losses) — 3 (43) — — (40)
Reclassification adjustments to
income(b) (96) 3 (8) — — (101)
Actuarial gains and other benefit
plan items — — — 1,374 11 1,385
Amortization of actuarial losses
and other benefit plan items — — — 248 7 255
Curtailments and
settlements—net — — — 268 (5) 263
Other 6 — — (62) (6) (62)
Income taxes 313 (12) 9 (656) (8) (354)
2,768
Balance, December 31, 2007 3,872 (32) 54 (1,567) (28) 2,299
Other comprehensive income/
(expense)––Pfizer Inc.(a):
Foreign currency translation
adjustments (5,898) — — — — (5,898)
Unrealized holding gains/
(losses) — 69 (193) — — (124)
Reclassification adjustments to
income(b) (2) — (20) — — (22)
Actuarial gains/(losses) and
other benefit plan items — — — (3,098) 22 (3,076)
Amortization of actuarial losses
and other benefit plan items — — — 130 3 133
Curtailments and
settlements—net — — — 280 3 283
Other 10 — — 129 35 174
Income taxes 629 (9) 73 994 (25) 1,662
(6,868)
Balance, December 31, 2008 (1,389) 28 (86) (3,132) 10 (4,569)
Other comprehensive income/
(expense)—Pfizer Inc.(a):
Foreign currency translation
adjustments 4,978 — — — — 4,978
Unrealized holding gains/
(losses) — 291 576 — — 867
Reclassification adjustments to
income(b) 5 (299) (143) — — (437)
Actuarial gains/(losses) and
other benefit plan items — — — (701) 154 (547)
Amortization of actuarial losses
and other benefit plan items — — — 291 (6) 285
Curtailments and
settlements—net — — — 390 (5) 385
Other 2 — — (158) (11) (167)
Income taxes (46) (14) (78) (57) (48) (243)
5,121
Balance, December 31, 2009 $ 3,550 $ 6 $ 269 $(3,367) $ 94 $ 552
(a) Amounts do not include foreign currency translation adjustments attributable to noncontrolling interests of $5 million in 2009, $35 million in 2008 and $6
million in 2007.
(b) The currency translation adjustments reclassified to income resulted from the sale of businesses.
66 2009 Financial Report